Arkolith/Insider Trading/MACK/Form 4

Radeljevic Ana

DirectorMERRIMACK PHARMACEUTICALS INC (MACK) · full profile →Form 4 · filed Jan 9, 2023
Net Buying
Open-Market Buys
$50K
Open-Market Sells
$0
Net Open-Market Flow
$50K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 6, 2023Buy(P)4K$12.03$50K4K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-001290) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML